Cargando…

MicroRNA-129-1-3p Represses the Progression of Triple-Negative Breast Cancer by Targeting the GRIN2D Gene

The aberrant expression of miRNA is strongly linked to numerous stages of triple-negative breast cancer (TNBC) progression, and it plays an indispensable role in the process from tumor onset and progress to invasion and metastasis. In this study, we first transfected miR-129-1-3p mimics and inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qi, Gu, Zehui, Tan, Qi, Ren, Liqun, Chen, Suxian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920657/ https://www.ncbi.nlm.nih.gov/pubmed/35295962 http://dx.doi.org/10.1155/2022/1549357

Ejemplares similares

MicroRNA‐129‐1‐3p protects cardiomyocytes from pirarubicin‐induced apoptosis by down‐regulating the GRIN2D‐mediated Ca(2+) signalling pathway
por: Li, Qi, et al.
Publicado: (2020)

MicroRNAs in regulation of triple-negative breast cancer progression
por: Piasecka, Dominika, et al.
Publicado: (2018)

Mechanism of microRNA regulating the progress of atherosclerosis in apoE-deficient mice
por: Lou, Xiaoqian, et al.
Publicado: (2021)

MicroRNAs and Triple Negative Breast Cancer
por: D’Ippolito, Elvira, et al.
Publicado: (2013)

P38 Signal Transduction Pathway Has More Cofactors on Apoptosis of SGC-7901 Gastric Cancer Cells Induced by Combination of Rutin and Oxaliplatin
por: Li, Qi, et al.
Publicado: (2019)

MYC and DNMT3A‐mediated DNA methylation represses microRNA‐200b in triple negative breast cancer
por: Pang, Yamei, et al.
Publicado: (2018)

New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer
por: Fu, Yeqin, et al.
Publicado: (2023)

MicroRNA-150 suppresses triple-negative breast cancer metastasis through targeting HMGA2
por: Tang, Wentao, et al.
Publicado: (2018)

MicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression
por: Nama, Srikanth, et al.
Publicado: (2019)

Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress
por: Li, Qi, et al.
Publicado: (2022)

Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling
por: Chen, Junqing, et al.
Publicado: (2018)

Distinct roles of GRIN2A and GRIN2B variants in neurological conditions
por: Myers, Scott J, et al.
Publicado: (2019)

MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome
por: Medimegh, Imen, et al.
Publicado: (2014)

MicroRNA-137 Inhibits Cancer Progression by Targeting Del-1 in Triple-Negative Breast Cancer Cells
por: Lee, Soo Jung, et al.
Publicado: (2019)

Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing
por: Chang, Yao-Yin, et al.
Publicado: (2015)

Tumor suppressor role of microRNA-1296 in triple-negative breast cancer
por: Phan, Binh, et al.
Publicado: (2016)

MicroRNA‐493 is a prognostic factor in triple‐negative breast cancer
por: Yao, Ling, et al.
Publicado: (2018)

Circulating microRNAs and their role in the immune response in triple-negative breast cancer
por: Piña-Sánchez, Patricia, et al.
Publicado: (2020)

Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer
por: Bajaj, Rajat, et al.
Publicado: (2020)

CRISPR interference and activation of the microRNA-3662-HBP1 axis control progression of triple-negative breast cancer
por: Yi, Baozhu, et al.
Publicado: (2022)

Long-lived monolithic micro-optics for multispectral GRIN applications
por: Lepicard, Antoine, et al.
Publicado: (2018)

MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer
por: Ding, Lei, et al.
Publicado: (2019)

MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer
por: Ouyang, Mao, et al.
Publicado: (2014)

MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer
por: Kahraman, Mustafa, et al.
Publicado: (2018)

Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity
por: Gupta, Ishita, et al.
Publicado: (2019)

Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype
por: Angius, Andrea, et al.
Publicado: (2020)

Three-microRNA expression signature predicts survival in triple-negative breast cancer
por: Wu, Xinquan, et al.
Publicado: (2020)

Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy
por: (Stămat), Liliana-Roxana Balahura, et al.
Publicado: (2023)

c‐Src promotes tumor progression through downregulation of microRNA‐129‐1‐3p
por: Okuzaki, Daisuke, et al.
Publicado: (2020)

MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2
por: Liu, Heng, et al.
Publicado: (2021)

Role of microRNA-129 in cancer and non-cancerous diseases (Review)
por: Deng, Bingpeng, et al.
Publicado: (2021)

Assessment of NMDA receptor genes (GRIN2A, GRIN2B and GRIN2C) as candidate genes in the development of degenerative lumbar scoliosis
por: KIM, KI-TACK, et al.
Publicado: (2013)

Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer
por: Cascione, Luciano, et al.
Publicado: (2013)

High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer
por: Cao, Zhi-Gang, et al.
Publicado: (2016)

MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017)

An integrated analysis of microRNAs regulating DNA damage response in triple-negative breast cancer
por: Kuthethur, Raviprasad, et al.
Publicado: (2023)

Extracellular Vesicles: The Landscape in the Progression, Diagnosis, and Treatment of Triple-Negative Breast Cancer
por: Dong, Menglu, et al.
Publicado: (2022)

Overexpression of microRNA-620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD
por: Wu, Chao, et al.
Publicado: (2019)

Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2016)

Study of Early Onset Schizophrenia: Associations of GRIN2A and GRIN2B Polymorphisms
por: Poltavskaya, Evgeniya G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1r7nmlscqroah48j42r81m363k